XWEL (XWELL, Inc. Common Stock) Stock Analysis - News
XWELL, Inc. Common Stock (XWEL) is a publicly traded Consumer Cyclical sector company. As of May 21, 2026, XWEL trades at $1.47 with a market cap of $11.18M and a P/E ratio of -0.29. XWEL moved +1.37% today. Year to date, XWEL is +236.72%; over the trailing twelve months it is +58.70%. Its 52-week range spans $0.26 to $2.20. Rallies surfaces XWEL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What changed in XWEL news today?
XWELL Reports $29.2M Revenue, Cuts Costs and Secures $31.3M Capital: XWELL reported 2025 revenue of $29.2 million while reducing cost of sales by 13%, operating expenses by 10% and G&A by 20%. In February 2026 XWELL opened a Penn Station wellness center, partnered with AI firm PieQ on a CDC biosecurity forecasting platform and raised $31.3 million in a private placement.
Wizenberg Gaelle Sandra bought 1.20K (~$1.99K) on Sep 11, 2024.
Wizenberg Gaelle Sandra bought 199 (~$368.15) on May 7, 2024.
Wizenberg Gaelle Sandra bought 100 (~$183) on Apr 26, 2024.
XWEL Analyst Consensus
XWEL analyst coverage data. Average price target: $0.00.
Common questions about XWEL
What changed in XWEL news today?
XWELL Reports $29.2M Revenue, Cuts Costs and Secures $31.3M Capital: XWELL reported 2025 revenue of $29.2 million while reducing cost of sales by 13%, operating expenses by 10% and G&A by 20%. In February 2026 XWELL opened a Penn Station wellness center, partnered with AI firm PieQ on a CDC biosecurity forecasting platform and raised $31.3 million in a private placement.
Does Rallies summarize XWEL news?
Yes. Rallies summarizes XWEL news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is XWEL research on Rallies investment advice?
No. Rallies provides research, data, and educational context for XWEL. It does not provide personalized investment advice.
